Steve Miller, Chief Operating Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 140,866 shares at $16.85 ($2.4M) on 2022-09-13, disclosed to the SEC on 2022-09-15.
Open-market sale of $2.4M CPRX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.85 | 75,000 | $1.3M | 53.0% |
| 2 | $17.01 | 25,000 | $425K | 17.8% |
| 3 | $17.01 | 25,000 | $425K | 17.8% |
| 4 | $17.11 | 7,933 | $136K | 5.7% |
| 5 | $17.11 | 7,933 | $136K | 5.7% |
| Total | $16.94 avg | 140,866 |
| $2.4M |
| 100% |
| Filing → |
| CPRX | SELL | 2024-08-22 | $4.1M | — | Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-11-23 | $1.6M | — | Filing → |